Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · Real-Time Price · USD
0.496
-0.034 (-6.45%)
At close: Dec 5, 2025, 4:00 PM EST
0.497
+0.002 (0.30%)
After-hours: Dec 5, 2025, 7:59 PM EST
Sangamo Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -108.91 | -97.94 | -257.83 | -192.28 | -178.29 | -121 | |
| Depreciation & Amortization | 7.85 | 9.36 | 22.19 | 20.56 | 17.64 | 13.37 | |
| Loss (Gain) From Sale of Assets | -1.03 | -1.03 | - | - | - | 0.22 | |
| Asset Writedown & Restructuring Costs | - | 5.52 | 155.01 | - | - | - | |
| Loss (Gain) From Sale of Investments | - | -0.27 | -2.33 | -1.24 | 2.84 | -0.83 | |
| Stock-Based Compensation | 10.23 | 12.38 | 27.36 | 31.65 | 32.96 | 25.71 | |
| Other Operating Activities | -0.24 | 0.33 | -5.22 | - | -6.51 | -0.19 | |
| Change in Accounts Receivable | 9.97 | 0.4 | 2.76 | 2.34 | -0.79 | 31.69 | |
| Change in Accounts Payable | -3.02 | -14.17 | 5.59 | 13.35 | -7.66 | 10.7 | |
| Change in Unearned Revenue | 12.66 | 13.43 | -161.16 | -91.33 | -84.2 | 216.55 | |
| Change in Income Taxes | 0.56 | 0.56 | -3.73 | - | - | - | |
| Change in Other Net Operating Assets | -4.23 | 4.29 | -7.49 | -6.67 | -9.24 | -6.35 | |
| Operating Cash Flow | -76.16 | -67.14 | -224.84 | -223.63 | -233.25 | 169.88 | |
| Capital Expenditures | -0.24 | -0.27 | -21.16 | -20.17 | -23.28 | -14.71 | |
| Sale of Property, Plant & Equipment | 1.48 | 1.95 | - | - | - | - | |
| Cash Acquisitions | - | - | - | - | -0.12 | -0.7 | |
| Investment in Securities | - | 35.84 | 174.69 | 79.46 | 271.6 | -256.21 | |
| Investing Cash Flow | 1.24 | 37.52 | 153.53 | 59.29 | 248.2 | -271.63 | |
| Issuance of Common Stock | 66.08 | 29.28 | 16.04 | 86.76 | 36.12 | 153.87 | |
| Repurchase of Common Stock | -3.13 | -0.9 | -1.45 | -2.1 | -3.26 | -0.77 | |
| Financing Cash Flow | 62.94 | 28.38 | 14.59 | 84.66 | 32.86 | 153.1 | |
| Foreign Exchange Rate Adjustments | 1.8 | -2.05 | 1.48 | 1.25 | -0.26 | -0.45 | |
| Net Cash Flow | -10.17 | -3.29 | -55.24 | -78.43 | 47.54 | 50.9 | |
| Free Cash Flow | -76.4 | -67.41 | -246 | -243.8 | -256.53 | 155.16 | |
| Free Cash Flow Margin | -232.38% | -116.62% | -139.59% | -219.05% | -231.73% | 131.28% | |
| Free Cash Flow Per Share | -0.31 | -0.33 | -1.41 | -1.58 | -1.77 | 1.15 | |
| Levered Free Cash Flow | -38.8 | -38.09 | -98.11 | -110.51 | -107.24 | 41.35 | |
| Unlevered Free Cash Flow | -38.8 | -38.09 | -98.11 | -110.51 | -107.24 | 41.35 | |
| Change in Working Capital | 15.94 | 4.51 | -164.03 | -82.32 | -101.9 | 252.59 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.